Find your bookmarks in your Independent Premium section, under my profile Weight loss jabs like Ozempic can cut the risk of heart attacks or strokes by a fifth, a “game-changing” new study has ...
A groundbreaking study has revealed that an anti-obesity jab containing semaglutide, a drug used to treat obesity, significantly reduces the risk of heart attacks and strokes, regardless of the ...
Its famous as a weight loss jab but effects are much more wide-ranging (Picture: Getty/Metro.co.uk) Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates.
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an analysis of a study funded by a drug manufacturer. Researchers looked ...
An anti-obesity drug could have additional health benefits including reducing the risk of heart attacks and strokes a new study has revealed. A five-year study was carried out by a team led ...